Enhanced brain delivery of oleanolic acid by GSH-PEGylated liposomes and its amelioration of scopolamine-induced cognitive dysfunction via multi-target regulation.

Yihuo Luo, Xiaokun Hong, Xiaohui Chen, Yanqi Liang, Feng Li, Xian'ai Shi, Xiongmei Huang

Abstract read

In one paragraph

Article in International journal of pharmaceutics: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yihuo LuoCollege of Biological Science and Engineering, Fuzhou University, Fuzhou 350116, PR China.

Xiaokun HongCollege of Biological Science and Engineering, Fuzhou University, Fuzhou 350116, PR China.

Xiaohui ChenDepartment of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou 350001, Fujian, China.

Yanqi LiangCollege of Biological Science and Engineering, Fuzhou University, Fuzhou 350116, PR China.

Feng LiCollege of Biological Science and Engineering, Fuzhou University, Fuzhou 350116, PR China.

Xian'ai ShiCollege of Biological Science and Engineering, Fuzhou University, Fuzhou 350116, PR China.

Xiongmei HuangDepartment of Burn and Plastic Surgery, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou 350001, Fujian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oleanolic acid (OA) exhibits pronounced neuroprotective effects in the central nervous system; however, its clinical translation is limited by poor solubility and low bioavailability. To overcome these limitations, we developed glutathione-PEGylated OA liposomes (GSH-PEG-OA-LIP) via a post-insertion method, achieving an load efficiency of 94.2%. In vivo imaging demonstrated that GSH-PEG modification significantly prolonged blood circulation and enhanced brain accumulation compared to unmodified liposomes. In a mouse model of scopolamine (SCOP)-induced cognitive deficit, GSH-PEG-OA-LIP treatment effectively reversed short- and long-term memory impairments. Biochemical analyses revealed that the treatment restored hippocampal cholinergic function by increasing acetylcholine (ACh) levels and choline acetyltransferase (ChAT) activity, while simultaneously alleviating oxidative stress through reduced malondialdehyde (MDA) content and increased superoxide dismutase (SOD) activity. Furthermore, molecular docking and molecular dynamics simulations confirmed stable interactions between OA and key signaling targets-specifically PKC, PI3Kγ, MEK, and IP3R-suggesting a multi-targeted mechanism of action. Collectively, these results highlight GSH-PEG-OA-LIP as an efficient brain-targeted delivery system and a promising therapeutic strategy for cognitive disorders.

Indexed as

Blood-brain barrierGSH-PEGylated liposomeMolecular dockingMolecular dynamics simulationOleanolic acid

Identifiers

PMID41800070

DOI10.1016/j.ijpx.2026.100509

PMCPMC12966699

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.